References
- Johnsson M, Barauskas J, Norlin A, Tiberg F. Physicochemical and drug delivery aspects of lipid-based liquid crystalline nanoparticles: a case study of intravenously administered propofol. J Nanosci Nanotechnol. 2006;9-10:3017–3024.
- Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, et al. Liquid crystalline nanoparticle dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res. 2005;22:2163–2173.
- Zhao XY, Zhang J, Zheng LQ, Li DH. Studies of cubosomes as a sustained drug delivery system. J Disp Sci Tech. 2004;25:795–799.
- Spicer PT. Progress in liquid crystalline dispersions: cubosomes. Curr Opin Colloid In. 2005;10:274–279.
- Naik A, Pechtold LARM, Potts RO, Guy RH. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J Controll Rel. 1995;37:299–306.
- Lai J, Chen J, Lu Y, Sun J, Hu F, Yin Z, et al. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. AAPS Pharm Sci Tech. 2009;10:960–966.
- Spicer PT. Cubosomes: bicontinuous cubic liquid crystalline nanostructured particles. In Schwarz JA, Contescu C, Putyera K, eds. Marcel dekker encyclopedia of nanoscience and nanotechnology. New York: Marcel dekker; 2003. pp 881–892.
- Yoo J, Shanmugam S, Song CK, Kim DD, Choi HG, Yong CS, et al. Skin penetration and retention of L-ascorbic acid 2-phosphate using multilamellar vesicles. Arch Pharm Res. 2008;31:1652–1658.
- van der Fits L, Mourits S, Voerman JSA, Kant M, Boon L, Laman JD, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 2009;182:5836–5845.
- Winter R. Synchrotron X-ray and neutron small-angle scattering of lyotropic lipid mesophases, model biomembranes and proteins in solution at high pressure. Biochim Biophys Acta. 2002;1595:160–184.
- Tamura S, Ohike A, Ibuki R, Amidon GL, Yamashita S. Tacrolimus is a class II low-solubility high permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats. J Pharm Sci. 2002;91:719–729.
- Trickler WJ, Nagvekar AA, Dash AK. A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS PharmSciTech. 2008;9:486–493.
- Gilliet M, Conrad C, Geiges M, Cozzio A, Thürlimann W, Burg G, et al. Psoriasis triggered by Toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol. 2004;140:1490–1495.
- Wu JK, Siller G, Strutton G. Psoriasis induced by topical imiquimod. Australas J Dermatol. 2004;45:47–50.
- Rajan N, Langtry JA. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clin Exp Dermatol. 2006;31:140–141.
- Fanti PA, Dika E, Vaccari S, Miscial C, Varotti C. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol. 2006;45:1464–1465.